Join NATF in the fight against blood clots. Donate today. Make a donation

Event Description

NATF is actively monitoring the situation around COVID-19. The health and safety of conference attendees and partners is our top priority. We will continue to assess the situation in the coming weeks and will communicate updates along the way by June 1. We remain dedicated to disseminating the most up-to-date science in CTEPH — weather in-person or virtually!

Earn up to 10.5 CME Credits!

The United States CTEPH Proceedings 2021 will provide a multidisciplinary framework for the evaluation and management of patients with chronic thromboembolic pulmonary hypertension (CTEPH). Covered topics will include:

  • The epidemiology of chronic thromboembolic disease in the US
  • Contemporary approaches to diagnosing CTEPH
  • The latest in surgical advancements
  • The role of pulmonary hypertension (PH) targeted medical therapy and balloon pulmonary angioplasty (BPA) in the management of inoperable CTEPH

The conference format will comprise didactic presentations, debates, and panel discussions involving national and international experts in the field. There will be scheduled opportunities throughout the symposium for interactive audience participation. Attendees will also be encouraged to submit and present scientific abstracts and unique clinical cases related to CTEPH and other large-vessel pulmonary vascular diseases.

Target Audience:

This program has been designed to provide internists, pulmonologists, cardiologists, cardiovascular surgeons, interventional cardiologists and radiologists, anesthesiologists, thoracic radiologists, nurses, and allied healthcare professionals with state-of-the-art information to evaluate and manage patients with CTEPH.

Learning Objectives:

  1. Discuss an updated understanding of the epidemiology and pathophysiology of CTEPH
  2. Describe the latest diagnostic modalities and evaluative approach to patients with suspected chronic thromboembolic disease
  3. Discuss the advancements in the surgical procedure, pulmonary thromboendarterectomy, currently available for patients with chronic thromboembolic disease and CTEPH
  4. Explain the role of balloon pulmonary angioplasty in the management of inoperable CTEPH
  5. Define the role of pulmonary hypertension targeted medical therapy in selected patient groups with CTEPH

Conference Chair:

  • William R. Auger, MD

Organizing Committee:

  • Sonja Bartolome, MD (University of Texas, Southwestern)
  • Todd Bull, MD (University of Colorado)
  • Richard N. Channick, MD (University of California, Los Angeles)
  • Michael Cuttica, MD (Northwestern University)
  • Jack Haney, MD (Duke University)
  • Gustavo Heresi, MD (Cleveland Clinic)
  • Michael M. Madani, MD (University of California, San Diego)
  • Vallerie McLaughlin, MD (University of Michigan)
  • Ivan Robbins, MD (Vanderbilt University)
  • Anjali Vaidya, MD (Temple University)
  • Alison Witkin, MD (MGH, Harvard University)

Event Location

The College of Physicians of Philadelphia, Mutter Museum

The Mütter Museum is housed in a beautiful New Beaux-Arts style building, constructed in 1909 and designed by Cope and Stewardson. The magnificent columned Marble Rotunda, with its view of a classic grand staircase, sets the stage for any occasion. The building’s unique spaces are perfect for this symposium.

Hotel Information

NATF recommends the following hotels for your stay, all of which are within a half-mileof the College of Physicians.

Agenda

FRIDAY 

SEPTEMBER 10, 2021

7:00–8:20 AM 
Registration and Breakfast
8:20–8:30 AM 
Welcome: William R. Auger, MD
8:30–10:00 AM 
Understanding CTEPH

8:30–9:00 AM: Transition from Acute PE to CTEPH: Implications for Future Therapeutics?

9:00-9:30 AM: Screening for Chronic Thromboembolic Disease and CTEPH

9:30–10:00 AM: The Ongoing Challenges of Diagnosing CTEPH

10:00–10:20 AM 

Coffee Break

10:20 AM–12:00 PM 

The Tools of Diagnosis

10:20–11:00 AM: Advances in CT and MR Imaging: Implications for CTEPH Diagnosis and Management

11:00–11:30 AM: The Art of Pulmonary Angiography

11:30 AM–12:00 PM: Exercise Testing in Chronic PE

12:00–1:30 PM 

Lunch

1:30–2:45 PM 
Interactive Case Presentations
  1. Symptomatic 6 Months Following a PE…What to Do?
  2. Is That Acute or Chronic Clot On CT?
  3. VQ, CT, Pulmonary Angiogram…Is It All Necessary?
2:45–3:00 PM 

Coffee Break

3:00–5:00 PM 
Surgery, Surgical Management, and Cases That Drive Our Surgical Colleagues Nuts!

3:00–3:20 PM: Distal Endarterectomy in the Setting of Severe PH and High PVR: Should It Be Done

3:20–3:40 PM: “Thou Shall Not Reperfuse Diseased Lungs”: Endarterectomy in the Setting of COPD or Other Chronic Lung Disease – Diagnostic and Technical Challenges

3:40–4:00 PM: Pulmonary Endarterectomy After Previous BPA Sessions With and Without Stent Placement: So, What’s the Big Deal?

4:00–4:20 PM: “May I ask for a different patient today?” What to Do When Your Patient Has HIT, Sickle Cell Anemia, Pulmonary Angiosarcoma, or is a Jehovah’s Witness

4:20–4:40 PM: The Patient with CTED: To Operate or Not to Operate

4:40–5:00 PM: Management of Complex Post-Op Complications – ECMO to the Rescue: Airway Bleeding, Severe Reperfusion Injury, Residual PH and RV Failure

5:30–7:30 PM 
Poster Presentation and Cocktail/Networking Reception
SATURDAY  

SEPTEMBER 11, 2021

7:30–8:00 AM 

Breakfast

8:00–8:10 AM 
Conference Announcements: William R. Auger, MD
8:10–8:40 AM 

Kenneth M. Moser Distinguished Scholar Lecture

The Challenges of Caring for CTEPH Patients in the U.S.

8:40–10:00 AM 
Nonsurgical Management of CTEPH: Medical

8:40–9:00 AM: Inoperable CTEPH: Defining the Role of Medical Treatment

9:00–9:20 AM: The Hematology of CTEPH: Perioperative Considerations

9:20–9:40 AM: Post-PTE Anticoagulation, Warfarin vs. DOACs: End of the INR?

9:40-10:00 AM: Life After PTE: Residual PH Assessment and Mechanical VTE Risk Mitigation

10:00–10:15 AM 

Coffee Break

10:15–11:30 AM 
Balloon Pulmonary Angioplasty: The New Frontier

10:15–10:45 AM: The Great Debate: Distal CTEPH – Getting to the Root of the Problem: PTE or BPA?

10:45–11:00 AM: Technical Considerations and Challenges in BPA

11:00–11:15 AM: BPA: How Much BPA Is Enough? Targets, Goals, and Limitations

11:15–11:30 AM: BPA After PTE: Whether to Consider, When to Do It

11:30 AM–12:30 PM 
Interactive Case Presentations
  1. Medical Management in a Non-PTE Candidate
  2. Handling Vessel Injury and Hemoptysis After a BPA
  3. BPA Combined with Medical Management in Inoperable CTEPH

Join NATF in the fight against blood clots. Donate today.

Make a donation

Twitter Facebook YouTube